These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 25427521)

  • 1. An open-label pilot study of homeopathic treatment of attention deficit hyperactivity disorder in children and youth.
    Brulé D; Sule L; Landau-Halpern B; Nastase V; Jain U; Vohra S; Boon H
    Forsch Komplementmed; 2014; 21(5):302-9. PubMed ID: 25427521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homeopathic treatment of children with attention deficit hyperactivity disorder: a randomised, double blind, placebo controlled crossover trial.
    Frei H; Everts R; von Ammon K; Kaufmann F; Walther D; Hsu-Schmitz SF; Collenberg M; Fuhrer K; Hassink R; Steinlin M; Thurneysen A
    Eur J Pediatr; 2005 Dec; 164(12):758-67. PubMed ID: 16047154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Randomized Three-Arm Double-Blind Placebo-Controlled Study of Homeopathic Treatment of Children and Youth with Attention-Deficit/Hyperactivity Disorder.
    Brulé D; Landau-Halpern B; Nastase V; Zemans M; Mitsakakis N; Boon H
    J Integr Complement Med; 2024 Mar; 30(3):279-287. PubMed ID: 37672605
    [No Abstract]   [Full Text] [Related]  

  • 4. Homeopathy for attention-deficit/hyperactivity disorder: a pilot randomized-controlled trial.
    Jacobs J; Williams AL; Girard C; Njike VY; Katz D
    J Altern Complement Med; 2005 Oct; 11(5):799-806. PubMed ID: 16296913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomised controlled trials of homeopathy in hyperactive children: treatment procedure leads to an unconventional study design. Experience with open-label homeopathic treatment preceding the Swiss ADHD placebo controlled, randomised, double-blind, cross-over trial.
    Frei H; Everts R; von Ammon K; Kaufmann F; Walther D; Schmitz SF; Collenberg M; Steinlin M; Lim C; Thurneysen A
    Homeopathy; 2007 Jan; 96(1):35-41. PubMed ID: 17227746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modafinil in children and adolescents with attention-deficit/hyperactivity disorder: a preliminary 8-week, open-label study.
    Boellner SW; Earl CQ; Arora S
    Curr Med Res Opin; 2006 Dec; 22(12):2457-65. PubMed ID: 17257460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective, naturalistic study of open-label OROS methylphenidate treatment in Chinese school-aged children with attention-deficit/hyperactivity disorder.
    Zheng Y; Wang YF; Qin J; Wang LW; Zou LP; Jin XM; Xu T; Wang Y; Qi YL; Gong ME; Yin QY; Mai JN; Jing J; Luo XY; Ma HW; Li HB; Xie L; Li Y; Kuang GF; Yi MJ; Wang F; Zhu XH; Yao YB
    Chin Med J (Engl); 2011 Oct; 124(20):3269-74. PubMed ID: 22088519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
    Quintana H; Cherlin EA; Duesenberg DA; Bangs ME; Ramsey JL; Feldman PD; Allen AJ; Kelsey DK
    Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment for hyperactive children: homeopathy and methylphenidate compared in a family setting.
    Frei H; Thurneysen A
    Br Homeopath J; 2001 Oct; 90(4):183-8. PubMed ID: 11680802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does OROS-methylphenidate improve core symptoms and deficits in executive function? Results of an open-label trial in adults with attention deficit hyperactivity disorder.
    Fallu A; Richard C; Prinzo R; Binder C
    Curr Med Res Opin; 2006 Dec; 22(12):2557-66. PubMed ID: 17166338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of a restricted elimination diet on the behaviour of children with attention-deficit hyperactivity disorder (INCA study): a randomised controlled trial.
    Pelsser LM; Frankena K; Toorman J; Savelkoul HF; Dubois AE; Pereira RR; Haagen TA; Rommelse NN; Buitelaar JK
    Lancet; 2011 Feb; 377(9764):494-503. PubMed ID: 21296237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atomoxetine hydrochloride in the treatment of children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: A placebo-controlled Italian study.
    Dell'Agnello G; Maschietto D; Bravaccio C; Calamoneri F; Masi G; Curatolo P; Besana D; Mancini F; Rossi A; Poole L; Escobar R; Zuddas A;
    Eur Neuropsychopharmacol; 2009 Nov; 19(11):822-34. PubMed ID: 19716683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attention-deficit/hyperactivity disorder with oppositional defiant disorder in Swedish children - an open study of collaborative problem solving.
    Johnson M; Ostlund S; Fransson G; Landgren M; Nasic S; Kadesjö B; Gillberg C; Fernell E
    Acta Paediatr; 2012 Jun; 101(6):624-30. PubMed ID: 22375727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term treatment outcomes with lisdexamfetamine dimesylate for adults with attention-deficit/hyperactivity disorder stratified by baseline severity.
    Ginsberg L; Katic A; Adeyi B; Dirks B; Babcock T; Lasser R; Scheckner B; Adler LA
    Curr Med Res Opin; 2011 Jun; 27(6):1097-107. PubMed ID: 21438796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An eight-week, open-trial, pilot feasibility study of trigeminal nerve stimulation in youth with attention-deficit/hyperactivity disorder.
    McGough JJ; Loo SK; Sturm A; Cowen J; Leuchter AF; Cook IA
    Brain Stimul; 2015; 8(2):299-304. PubMed ID: 25533244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donepezil use in children and adolescents with tics and attention-deficit/hyperactivity disorder: an 18-week, single-center, dose-escalating, prospective, open-label study.
    Cubo E; Fernández Jaén A; Moreno C; Anaya B; González M; Kompoliti K
    Clin Ther; 2008 Jan; 30(1):182-9. PubMed ID: 18343255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multi-centre, randomised, open-label study of atomoxetine compared with standard current therapy in UK children and adolescents with attention-deficit/hyperactivity disorder (ADHD).
    Prasad S; Harpin V; Poole L; Zeitlin H; Jamdar S; Puvanendran K;
    Curr Med Res Opin; 2007 Feb; 23(2):379-94. PubMed ID: 17288692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative consecutive case series of 20 children with a diagnosis of ADHD receiving homeopathic treatment, compared with 10 children receiving usual care.
    Fibert P; Relton C; Heirs M; Bowden D
    Homeopathy; 2016 May; 105(2):194-201. PubMed ID: 27211327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.